DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Gelfand EV, Cannon CP.
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors.
J Am Coll Cardiol 2006; 47: 1919-1926
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.